Manifold Bio

Manifold Bio builds AI models for therapeutic design trained on proprietary experimental data generated at unprecedented scale. Our in vivo-centric discovery platform produces millions of experimentally validated protein designs per campaign creating the datasets that make our models

Manifold Bio builds AI models for therapeutic design trained on proprietary experimental data generated at unprecedented scale. Our in vivo-centric discovery platform produces millions of experimentally validated protein designs per campaign creating the datasets that make our models

Manifold Bio builds AI models for protein therapeutic design trained on proprietary experimental data generated at unprecedented scale. Our in vivo-centric discovery platform produces millions of experimentally validated protein designs per campaigncreating the datasets that make our

Manifold Bio builds AI models for protein therapeutic design trained on proprietary experimental data generated at unprecedented scale. Our in vivo-centric discovery platform produces millions of experimentally validated protein designs per campaigncreating the datasets that make our

Manifold Bio builds AI models for protein therapeutic design trained on proprietary experimental data generated at unprecedented scale. Our in vivo-centric discovery platform produces millions of experimentally validated protein designs per campaign creating the datasets that make our

Manifold Bio builds AI models for protein therapeutic design trained on proprietary experimental data generated at unprecedented scale. Our in vivo-centric discovery platform produces millions of experimentally validated protein designs per campaign creating the datasets that make our

Manifold Bio is a platform biotechnology company pioneering AI-guided protein design and massively multiplexed in vivo screening to unlock tissue-targeted medicines and organism-scale models of living systems. Using proprietary molecular barcoding technology we screen hundreds of thou

Manifold Bio is a platform biotechnology company pioneering AI-guided protein design and massively multiplexed in vivo screening to unlock tissue-targeted medicines and organism-scale models of living systems. Using proprietary molecular barcoding technology we screen hundreds of thou

Manifold Bio is a platform biotechnology company pioneering AI-guided protein design and massively multiplexed in vivo screening to unlock tissue-targeted medicines and organism-scale models of living systems. Using proprietary molecular barcoding technology we screen hundreds of thou

Manifold Bio is a platform biotechnology company pioneering AI-guided protein design and massively multiplexed in vivo screening to unlock tissue-targeted medicines and organism-scale models of living systems. Using proprietary molecular barcoding technology we screen hundreds of thou

Manifold Bio builds AI models for protein therapeutic design trained on proprietary experimental data generated at unprecedented scale. Our in vivo-centric discovery platform produces millions of experimentally validated protein designs per campaign creating the datasets that make our

Manifold Bio builds AI models for protein therapeutic design trained on proprietary experimental data generated at unprecedented scale. Our in vivo-centric discovery platform produces millions of experimentally validated protein designs per campaign creating the datasets that make our

Manifold Bio builds AI models for protein therapeutic design trained on proprietary experimental data generated at unprecedented scale. Our in vivo-centric discovery platform produces millions of experimentally validated protein designs per campaign creating the datasets that make our

Manifold Bio builds AI models for protein therapeutic design trained on proprietary experimental data generated at unprecedented scale. Our in vivo-centric discovery platform produces millions of experimentally validated protein designs per campaign creating the datasets that make our

PositionManifolds AI team is actively training protein foundation models on our proprietary experimental datasets. Our generative antibody design model mBER has already demonstrated controllable de novo binder design across multiple million-scale screening campaigns and the team is no

PositionManifolds AI team is actively training protein foundation models on our proprietary experimental datasets. Our generative antibody design model mBER has already demonstrated controllable de novo binder design across multiple million-scale screening campaigns and the team is no